Ibandronate Sodium Tablets

This solicitation, SPE2D2-25-R-0019, aims to establish a national contract for Ibandronate Sodium Tablets as part of the Pharmaceutical Prime Vendor (PPV) Program. The awarded contractor will serve as a national supply source, providing these drugs for purchase by DLA and VA customers through the PPV program. The contractor will receive payments from the PPV contractors (DLA and VA) and must establish business-to-business agreements with them within 15 days of award. Offerors should note that the contractor cannot assign its rights to receive payment under this contract, and disputes with PPV contractors will not give rise to claims under the Disputes Clause. The complete order quantity must be delivered to the PPV contractors within 15 calendar days after receipt of order. Proposals are due by September 22, 2025 at 3:00 PM EST.

Notice ID

b4edba82212d4da6a258c458be450126

Solicitation Number

SPE2D2-25-R-0019

NAICS Code

325412

Classification Code

6505